The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor cells and clinical outcomes in men with metastatic hormone sensitive prostate cancer treated with enzalutamide and docetaxel: Analysis of the ENZADA trial.
 
Landon Brown
Consulting or Advisory Role - Merck; Pfizer; Seattle Genetics/Astellas
 
Claud Grigg
Consulting or Advisory Role - Astellas Pharma; AVEO; Bayer; Eisai; Exelixis; Xencor
Research Funding - Tempus
 
Danielle Boselli
Employment - TERUMO (I)
Leadership - TERUMO (I)
Stock and Other Ownership Interests - TERUMO (I)
Travel, Accommodations, Expenses - TERUMO (I)
 
James Symanowski
Consulting or Advisory Role - Astellas Pharma; Camurus; CARsgen Therapeutics; Fusion Pharmaceuticals; Immatics; Jazz Pharmaceuticals; Lilly; Merus
 
Jason Zhu
Consulting or Advisory Role - Bayer; Exelixis; NGM Biopharmaceuticals
Travel, Accommodations, Expenses - UroToday
 
Sarah Norek
No Relationships to Disclose
 
Xhevahire Begic
No Relationships to Disclose
 
Derek Raghavan
Consulting or Advisory Role - Perthera
 
Earle Burgess
Stock and Other Ownership Interests - Becton Dickinson; Exelixis; Gilead Sciences; Macrogenics
Honoraria - Exelixis
Consulting or Advisory Role - Johnson & Johnson
Research Funding - Astellas Pharma; Pfizer